ALUMNI
GOZUACIK Lab former members (Alumni):
2018
Muhammed Kocak (MSc): The Institute of Cancer Research London, UK.
Biran Musul (MSc):
2017
Secil Erbil (PhD): Denmark.
Hacer Ezgi Karakas (PhD): Austria.
Ozlem Yedier (MSc): PhD student in Koc University.
Seval Kilic (MSc): PhD student in iBG (International Biomedicine and Genome Institute).
2016
Dr Cenk Kig (Postdoc, PhD degree obtained in Istanbul): Faculty Member in Yeni Yuzyil University.
Dr Basak Ozata (Postdoc, PhD degree obtained in Germany):
Dr Oznur Bayraktar (PhD): Faculty Member in Okan University, Istanbul.
Esra Sinoplu (MSc): PhD student in METU.
Dr Amal Arachiche (Postdoc, PhD degree obtained in France):
2015
Dr. Kumsal Ayse Tekirdag (PhD): Postdoctoral Researcher in the Albert Einstein College of Medicine, NY, USA.
2013
Dr Ozlem Oral (Postdoc, PhD degree obtained in Japan): SUNUM Nanotechnology Center Staff Scientist.
Dr. Karin Eberhart (Postdoc, PhD degree obtained in Germany): Researcher in Merck Drug Company, Germany.
Dr. Ilyas İnci (Postdoc, PhD degree obtained in Turkey): Postdoctoral Researcher in the Massachusetts Institute of Technology (MIT), USA.
2012
Dr. Gozde Korkmaz (PhD): Postdoctoral Researcher in The Netherlands Cancer Institute (NKI), Holland.
Dr. Ster Irmak (Postdoc, PhD degree obtained in Germany): Faculty Member in Bilgi University, Istanbul.
2011
Dr. Geraldine Mitou (Postdoc, PhD degree obtained in France): Researcher in Toulouse Cancer Research Center, France
Zeynep Itah (MSc): PhD student in the University of Massachusetts (UMAS), USA.
Oznur Bayraktar (MSc): PhD student in the Gozuacik Lab.
2010
Gökçen Gökçe (MSc): Patent Specialist in Ankara Patent, Istanbul.
2009
Dr Devrim Oz-Arslan (Postdoc, PhD degree obtained in Greece): Faculty Member in Acibadem University, Istanbul.
Derin Demiroglu (MSc): Clinical Trial Associate (CTA) in Pfizer Drug Company, Istanbul.
Yekta Yamaner (MSc): Clinical Trial Associate (CTA) in Pfizer Drug Company, Istanbul.
2008
Ferah Gulacti (MSc): PhD student in Oxford University, UK.
September 2006
G Lab was established.